-----Oorspronkelijk bericht-----
Van: Renee Marton <[log in to unmask]>
Aan: [log in to unmask] <[log in to unmask]>
Datum: donderdag 2 september 1999 20:59
Onderwerp: Re: coenzyme Q10 and NADH


>>> but what is NADH?  <<<

Date:    Wed, 24 Feb 1999 00:09:13 -0500
From:    judith richards <[log in to unmask]>
Subject: News-ENADA for CFS/Parkinsons/Alzheimers

http://biz.yahoo.com/bw/990223/bw0094_2.html

Company Press Release

ENADA - A Nutritional Supplement for Healthy Individuals Desiring More
Natural Energy

A Clinical Trial Reports Proven Energy Enhancement Using Strict FDA
Testing Guidelines to Alleviate Symptoms of Chronic Fatigue Syndrome

WASHINGTON, D.C.--(BUSINESS WIRE)--Feb. 23, 1999-- Menuco Corporation
announced today that
ENADA®, a natural energy-enhancing nutritional supplement, tested by
researchers at Georgetown University Medical Center, has achieved
significant improvement in relieving the symptoms of people suffering
from Chronic Fatigue Syndrome (CFS).

CFS is a debilitating disorder caused by unexplainable tiredness or lack
of energy, and has no known cure. According to the Centers for Disease
Control, over 14 million people in the U.S. experience chronic fatigue
symptoms. The Georgetown clinical trials focused on people diagnosed
with CFS; however, ENADA is also a nutritional supplement for healthy
individuals who desire additional energy.

ENADA is one of the first nutritional supplements to be tested using
strict FDA guidelines to determine its safety and effectiveness.
Georgetown doctors found that 31% of the patients who took ENADA
achieved significant improvement in the relief of their symptoms. In a
follow-up study, 72% of the patients achieved positive results over a
longer period of time. The double-blind, placebo-controlled human
clinical trial results have recently been published in a prominent
medical peer-reviewed journal called ``Annals of Allergy, Asthma and
Immunology.'' The findings of these clinical trials are being presented
at the February 23, 1999 press conference at Georgetown University
Medical Center.

``Eighty percent of Americans state that fatigue is their number one
health complaint. We to demonstrate through sound scientific studies,
not marketing hype, that ENADA is both safe and effective in providing
energy enhancement to alleviate the symptoms of CFS, a debilitating
disorder which affects half a million Americans,'' said Matt
Fitzsimmons,
president, Menuco Corporation. ``Dr. Bellanti and his research
colleagues at Georgetown University Medical Center have successfully
demonstrated ENADA's effectiveness in increasing energy,'' says
Fitzsimmons.

ENADA is the brand name for stabilized, absorbable NADH (nicotinamide
adenine dinucleotide plus high-energy hydrogen). It is the only
patented, stabilized, absorbable, oral form of NADH currently on the
market. For years, research scientists have known that NADH a natural
coenzyme plays an important role in the body's cellular energy producing
function. NADH occurs naturally in the muscle tissue of fish, poultry
and cattle - key food sources in the
human diet. However, the human body absorbs miniscule amounts of NADH
ingested from food sources. Also it is known that the more NADH a cell
has, the more energy it can produce; therefore, the more energy a person
has.

In 1996, ENADA received an Investigative New Drug (IND) acceptance from
the FDA allowing ENADA to begin a human double-blind,
placebo-controlled, crossover study following strict pharmaceutical and
drug testing guidelines. The protocol was recognized by the FDA and
conducted at the prestigious Georgetown University Medical Center in
Washington, DC. (The IND number is 49,635 and the original working name
of the product was Birmadil.)

ENADA is available from Menuco Corporation under the Menuco brand. Also,
Menuco has selected a limited number of strategic partners to facilitate
national distribution. To this end, the company has established
marketing, private-labeling and distribution agreements with major
retailers and companies including General Nutrition Center (GNC),
KAL-Nutraceutical Corporation, Natrol, Inc., The Vitamin Shoppe, and
Weider/Schiff Nutrition. Additionally, several important catalog
organizations market ENADA, including Carotec and Pro-Health/CFIDS
buyer's club.

``We are indeed excited about partnering with Menuco to market our own
private-label version of Natrol® ENADA NADH to professional health
stores,'' says Elliott Balbert, CEO, Natrol, Inc. ``Our customers are
seeking the highest quality supplements supported by scientific studies.
Natrol's ENADA is certainly one of those products. We are glad to be
providing our customers with this stabilized, patented, oral form of
NADH,'' says Balbert.

Georgetown researchers are planning a large scale Chronic Fatigue
Syndrome study using ENADA to further explore its effectiveness for CFS.
Also, Georgetown researchers are conducting an FDA approved clinical
trial testing ENADA to prevent the mental deterioration, memory lapses,
and concentration difficulties associated with Alzheimer's disease. This
study is being conducted under the direction of the department of
neurology at Georgetown University
Medical Center. ENADA has shown promise in Europe when used for patients
with Alzheimer's and PARKINSON'S diseases.

Birkmayer Laboratories in Vienna, Austria and Menuco Corporation
sponsored the CFS study using ENADA. Georg Birkmayer, MD, Ph.D.,
world-renowned biochemical researcher and director of the Birkmayer
Institute for Parkinson Therapy, developed the first stabilized,
absorbable oral NADH supplement, a result of a decade of research. He is
also the first to use NADH therapeutically to stimulate the body to
produce naturally the key brain chemicals
responsible for energy production and muscle coordination. ENADA is
currently available in all health food stores in the United States,
including GNC and The Vitamin Shoppe, and through catalog sales. ENADA
is manufactured and packaged by Menuco through a licensing agreement
with MERCK Pharmaceuticals in Austria - MERCK Kommanditgesellschaft Auf
Aktien & Co.

For additional information, visit these Web sites at
http://www.enada.com and http://www.menuco.com.
--
Judith Richards, London, Ontario, Canada
<[log in to unmask]>